Atlas Trials

HBsAg Seroclearance in Adults With HBV Related Liver Fibrosis After Receiving Combined Therapy of Peg-IFN and Tenofovir.

Clinical trial NCT04640129 · UNKNOWN

Trial details

NCT number
NCT04640129
Sponsor
Third Affiliated Hospital, Sun Yat-Sen University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Liver Fibrosis
Start date
2021-01-01
Primary completion
2025-11-01
Enrollment
336

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.